Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Jan 29, 2009


Alnylam Pharmaceuticals has promoted Akshay Vaishnaw to the position of senior vice president of clinical research.

Vaishnaw previously served as Alnylam’s vice president of clinical research.

Pfizer has named Cathy Pachuk as senior director of delivery technology at its Research Technology Center, which focuses on, among other things, the company’s RNAi therapeutics efforts.

The company has also appointed C. Satishchandran as chief technology officer of the RTC.

Both Pachuk and Satishchandran were co-founders of Nucleonics, a now-defunct developer of expressed RNAi-based drugs. The company was shut down last year amid legal wrangling between the co-founders and senior management (see RNAi News, 11/6/2008).

Dicerna Pharmaceuticals has appointed Ronald Kahn to its scientific advisory board.

Kahn is currently a senior investigator at the Joslin Diabetes Center, where he heads the Joslin Section on Obesity and Hormone Action. He is also a professor of medicine at Harvard Medical School, according to Dicerna.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.